Educational Webinars

The EUSOBI and especially its Young Club, is proud to present a series of interactive, cased-based lectures, which aim at improving your clinical skills and answer your questions on breast imaging, from basic to advanced. The webinars are oriented to different levels of expertise, and provide worldwide interactive teaching on basic and advanced topics related to the diagnosis, staging and treatment of breast cancer. Each webinar is presented by one of our EUSOBI experts and we give you the opportunity to ask questions in our session.

Webinar places are limited and will be offered on a first-come, first-served basis. Early registration is recommended. The webinars are open for EUSOBI members only. Additionally, EUSOBI members will be able to view the webinar recording online at the EUSOBI website about 2-3 weeks after the webinar.

Webinar Series 1 // 2020 // Tips and Tricks in Breast MRI

The first series of webinars was entirely dedicated to the most complex and useful examination, Breast MRI. The experts were focusing on both technical and clinical issues and have addressed protocols, indications and reporting of breast MRI. Recordings of the webinars are available for EUSOBI Members (scroll down to RECORDINGS).


Webinar Series 2 // 2021 // Advancements in Mammography

The second series of webinars is dedicated to Mammography. Experts will present the most novel x-ray-based imaging modalities clinically available for breast imaging and currently under research that could have a role in the future; offer balanced content between cutting edge science and good everyday practice; update on the role of different available modalities in screening; and discuss the role of artificial intelligence in screening and diagnosis of breast cancer.


  • 2.1 / What is personalized screening? Francesca Caumo, Verona/IT
  • 2.2 / The role of Digital Breast Tomosynthesis in screening and clinical practice Sophia Zackrisson, Malmö/SE
  • 2.3 / Tomo-guided biopsy and Contrast-enhanced Tomosynthesis Daniela Bernardi, Milan/IT
  • 2.4 / Contrast-enhanced Mammography: Technique and protocols Marc Lobbes, Sittard-Geleen/NL
  • 2.5 / Contrast-enhanced Mammography: Clinical applications Fabienne Thibault, Paris/FR
  • 2.6 / Contrast-enhanced Mammography: Experience from two centers – Session 1 Jonathan James, Nottingham/UK
    >>> registration is open
  • 2.7 / Contrast-enhanced Mammography: Experience from two centers – Session 2 Eva M. Fallenberg, Munich/DE
  • 2.8 / Applications of AI in screening Karin Dembrower, Stockholm/SE & Valeria Romeo, Naples/IT
  • 2.9 / Breast CT Magda Marcon, Zurich/CH
  • 2.10 / Phase Contrast Mammography Marco Stampanoni, Villigen/CH

CME Info

The EUSOBI Webinar Series 2 – Advancements in Mammography has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 1 European CME credit (ECMEC®s) per webinar. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at

According to UEMS regulations, attendees can only claim CME credits if the whole webinar has been attended. You will need to complete the event evaluation form after the webinar. As part of this process partcipants’ attendance will be monitored throughout the event. Only live-viewing can be accredited.


Next Webinar

MAY 12, 2021: EUSOBI Webinar 2.6 / Contrast-enhanced Mammography: Experience from two centers – Session 1

Speaker: Jonathan James, Nottingham/UK
Moderators: Mirjam Wielema, Groningen/NL; Nisha Sharma, Leeds/UK
Date: Wednesday, May 12, 2021
Time: 17:00-18:00 CEST

What can you expect from this webinar?
Contrast enhanced mammography (CESM) has been used in the symptomatic breast service in Nottingham for over 7 years. The webinar will describe the routine use of CESM at our centre, review the evidence from our own practice and the literature and provide a case-based review of CESM in symptomatic setting.

What will you learn during this webinar?
– To understand the evidence for the use of CESM in a symptomatic breast clinic
– To see how CESM can assist the local staging of symptomatic primary breast cancer
– To become familiar with reporting CESM in the symptomatic setting

Registration is online here:


Please CLICK HERE to find further details regarding our webinar sponsors.


MAY 26, 2021: EUSOBI Webinar 2.7 / Contrast-enhanced Mammography: Experience from two centers - Session 2

Speaker: Eva M. Fallenberg, Munich/DE
Moderators: Federica Leone, Milan/IT; Monique Dorrius, Groningen/NL
Date: Wednesday, May 26, 2021
Time: 17:00-18:00 CEST

JUN 1, 2021: EUSOBI Webinar 2.8 / Applications of AI in screening

Speakers: Karin Dembrower, Stockholm/SE; Valeria Romeo, Naples/IT
Moderator: Doris Leithner, New York/US
Date: Tuesday, June 1, 2021
Time: 17:30-18:45 CEST

JUL 6, 2021: EUSOBI Webinar 2.9 / Breast CT

Speaker: Magda Marcon, Zurich/CH
Moderators: Marianna Fanizza, Pavia/IT; Ritse M. Mann, Nijmegen/NL
Date: Tuesday, July 6, 2021
Time: 17:30-18:30 CEST

JUL 6, 2021: EUSOBI Webinar 2.10 / Phase Contrast Mammography

Speaker: Marco Stampanoni, Villigen/CH
Moderators: Maria Adele Marino, Messina/IT; Pascal Baltzer, Vienna/AT
Date: Thursday, July 15, 2021
Time: 17:00-18:00 CEST


APR 15, 2021: EUSOBI Webinar 2.5 / Contrast-enhanced Mammography: Clinical applications

Speaker: Fabienne Thibault, Paris/FR
Moderator: Daly Avendano, Monterrey/MX; Katja Pinker, New York/US
Date: Thursday, April 15, 2021
Time: 17:00-18:00 CEST

What can you expect from this webinar?
Contrast-enhanced Mammography (CEM) is being increasingly used in routine practice. Using a panel of clinical cases, we will illustrate its main indications and its contribution to oncological diagnosis and therapeutic management. This includes diagnostic work-up of suspicious findings on mammography and/or US, determination of the initial tumour extent, evaluation of response to systemic treatment, aiding preoperative lesion localisation and diagnosing cancer recurrence. The clinical performance of CEM will be discussed in comparison with conventional mammography and ultrasound, and with breast MRI.

What will you learn during this webinar?
− The utility of CEM in daily practice both at the diagnostic stage and during the successive steps of breast cancer management
− Getting aware of advantages and limitations of CEM compared to breast MRI
− Getting to know some particular features of CEM images encountered during interpretation

MAR 24, 2021: EUSOBI Webinar 2.4 / Contrast-enhanced Mammography: Technique and protocols

Speaker: Marc Lobbes, Sittard-Geleen/NL
Moderators: Thiemo van Nijnatten, Maastricht/NL; Rubina Manuela Trimboli, Milan/IT
Date: Wednesday, March 24, 2021
Time: 17:00-18:00 CET

What you can expect from this webinar?
Contrast-enhanced mammography (CEM) is an upcoming breast imaging modality that relies on the injection of iodine based contrast agent and dual-energy mammography. The increased acceptance of CEM can be deducted from the increasing amount of installments and growing number of scientific publications. CEM indications might include: problem solving tool in equivocal findings during conventional mammography, preoperative staging, response monitoring in women treated with NAC, high risk screening, etc. However, it also starts with acquiring a robust CEM image. Hence, the current webinar will focus on the technical principles of CEM, patient handling and image acquisition. Some of the most common questions when initiating CEM within your breast center will be addressed, as well as the most common indications for CEM.

What can you learn during this webinar?
– Learn how to set up a CEM program in your hospital.
– Learn to acquire a high quality CEM image and know the technical principles behind it.
– Learn to cope with the most common artefacts and pitfalls.
– Discuss the most common indications for CEM.

FEB 25, 2021: EUSOBI Webinar 2.3 / Tomo-guided Biopsy and Contrast-enhanced Tomosynthesis

Speaker: Daniela Bernardi, Milan/IT
Moderator: Lucia Grana, Lugo/ES
Date: Thursday, February 25, 2021
Time: 17:30-18:30 CET

FEB 9, 2021: EUSOBI Webinar 2.2 / The role of Digital Breast Tomosynthesis in screening and clinical practice

Speaker: Sophia Zackrisson, Malmö/SE
Moderator: Heike Preibsch, Tübingen/DE
Date: Tuesday, Feburary 9, 2021
Time: 17:00-18:00 CET

What can you expect from this webinar?
This lecture will cover the basics and advances of digital breast tomosynthesis, DBT, and its role in breast cancer screening and clinical breast imaging. Scientific background data will be presented, and cases will be used to illustrate pearls and pitfalls with DBT in different situations.

What can you learn during this webinar?
– the technique behind digital breast tomosyntesis, strengths and limitations
– the current scientific evidence and recommendations for use of DBT in screening
– clinical situations where DBT might be useful

JAN 27, 2021: EUSOBI Webinar 2.1 / What is personalized screening?

Speaker: Francesca Caumo, Verona/IT
Moderator: Elisabetta Giannotti, Nottingham/UK
Date: Wednesday, January 27, 2021
Time: 17:00-18:00 CET

What can you expect from this webinar?
Decide to undergo screening is an individual choice. The main questions are: how large the benefit of screening is in terms of reduced breast cancer mortality and how substantial the harm is in terms of interval cancers (defined as a cancer diagnosed after a negative mammographic screen and before the next routine screen), reduction of sensibility of mammography in dense breast and overdiagnosis, which is defined as the detection of cancers with screening which would not have become clinically apparent in the woman’s lifetime in the absence of screening.

There are two strategies to improve the effect of a screening program: find a better first level test- Automated Breast Ultrasound System (ABUS)-Magnetic Resonance Imaging (MRI)-Digital Breast Tomosynthesis (DBT)-Hand-Held Ultrasound (HHUS) or try the way to overcoming effect of density and make a better risk classification to have different screening strategies including other imaging modalities, in addition to mammography, that might improve early detection of breast cancer.
International strategy (Wisdom Study; Dense Study, MyPeBs) is thinking about tailored screening modifying interval screen and using other modality.

The objective of the webinar is to describe this experience and show our project: RiBS (RiskBasedScreening)